Discussion on the persistent symptoms following Lyme disease, a contentious medical area marked by a severe disagreement over etiology and treatment. The consensus, represented by the Infectious Diseases Society of America (IDSA), labels the chronic condition Post-Treatment Lyme Disease Syndrome (PTLDS), arguing it is a post-infectious syndrome with unclear cause, while the opposing view advocates for Chronic Lyme Disease (CLD), which posits ongoing, active infection. Research shows that while two U.S. trials indicated intravenous ceftriaxone efficacy for fatigue, this treatment is generally not recommended due to high adverse event rates and IV access risks, which other analyses confirm lead to increased patient morbidity. This polarization has led to a "Medical Civil War" where practitioners who treat CLD with prolonged antibiotics often face r ...